[1]张振山,姚天宇,许 迪.清胃汤联合四联疗法治疗幽门螺杆菌阳性胃溃疡临床研究[J].陕西中医,2021,(2):163-166.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.007]
　ZHANG Zhenshan,YAO Tianyu,XU Di.Effect of Qingwei decoction combined with quadruple therapy on helicobacter pylori positive gastric ulcer and its related mechanism[J].,2021,(2):163-166.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.007]
点击复制

清胃汤联合四联疗法治疗幽门螺杆菌阳性胃溃疡临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年2期
页码:
163-166
栏目:
临床研究
出版日期:
2021-02-05

文章信息/Info

Title:
Effect of Qingwei decoction combined with quadruple therapy on helicobacter pylori positive gastric ulcer and its related mechanism
作者:
张振山; 姚天宇; 许 迪
(沧州中西医结合医院,河北 沧州 061001)
Author(s):
ZHANG Zhenshan; YAO Tianyu; XU Di
(Cangzhou Integrated Traditional Chinese and Western Medicine Hospital,Cangzhou 061001,China)
关键词:
胃溃疡;  幽门螺杆菌;  四联疗法;  清胃汤;  血清转化生长因子-β1;  细胞外调节蛋白激酶 1/2
Keywords:
Gastric ulcer;  Helicobacter pylori;  Quadruple therapy;  Qingwei decoction;  TGF-β1;  ERK1/2
分类号:
R 573
DOI:
DOI:10.3969/j.issn.1000-7369.2020.02.007
文献标志码:
A
摘要:
目的:观察清胃汤联合四联疗法治疗幽门螺杆菌(HP)阳性胃溃疡的临床疗效,初步探讨相关机制。方法:将86例HP阳性胃溃疡患者按照随机数字表法分为治疗组和对照组各43例,对照组予以四联疗法,治疗组予以清胃汤联合四联疗法,疗程均为6周,比较两组治疗前后中医证候评分、HP根除率、溃疡复发率和血清转化生长因子-β1(TGF-β1)、细胞外调节蛋白激酶 1/2(ERK1/2)和表皮生长因子受体(EGFR)水平,治疗前后对两组进行胃镜检查,比较两组溃疡直径、底部厚苔面积、再生上皮面积和溃疡周围黏膜充血面积,并比较两组胃镜疗效。结果:治疗组治疗后胃脘疼痛、胸胁胀满、嗳气反酸、纳差食少、胃脘烧灼感评分均低于对照组(均P<0.05),溃疡直径、底部厚苔面积、溃疡周围黏膜充血面积均小于对照组(均P<0.05),再生上皮面积大于对照组(P<0.05); 血清TGF-β1水平低于对照组(P<0.05),ERK1/2、EGFR水平均高于对照组(均P<0.05),胃镜疗效、HP根除率均高于对照组(均P<0.05),复发率低于对照组,差异具有统计学意义(P<0.05)。结论:清胃汤联合四联疗法可有效改善中医证候,促进溃疡愈合,提高HP根除率和内镜疗效,降低溃疡复发率,治疗HP阳性胃溃疡效果显著,其机制可能与调节患者血清TGF-β1、ERK1/2、EGFR含量有关。
Abstract:
Objective:To observe the clinical effect of Qingwei decoction combined with quadruple therapy in the treatment of helicobacter pylori(HP)positive gastric ulcer and to preliminarily explore the related mechanism.Methods:86 patients with HP positive gastric ulcer were divided into two groups according to random number table method,with 43 patients in each group.The control group received quadruple therapy,and the treatment group received traditional Chinese medicine Qingwei decoction combined with quadruple therapy,with a course of 6 weeks,compare the two groups before and after treatment of TCM syndrome score,HP eradicate rate,ulcer recurrence rate and serum levels of transforming growth factor β1(TGF-β1),extracellular regulated protein kinase 1/2(ERK1/2)and epidermal growth factor receptor(EGFR)levels.Gastroscopy was performed in both groups before and after treatment.The diameter of ulcer,the area of thick coating at the bottom,the area of regenerated epithelium and the area of hyperemic mucosa around ulcer were compared between the two groups,and the efficacy of gastroscopy was compared between the two groups.Results:After treatment,the scores of gastral cavity pain,fullness chest and hypochondrium,belching acid regurgitation,poor appetite,and gastral cavity burning sensation in the treatment group were all lower than those in the control group(all P<0.05).The ulcer diameter,the area of thick coating at the bottom,the area of hyperemic mucosa around the ulcer were smaller than those in the control group(all P<0.05),and the area of regenerated epithelium was larger than that in the control group(P<0.05).Serum TGF- β1 level was lower than the control group(P<0.05),ERK1/2,EGFR level were higher than the control group(all P<0.05),gastroscopy efficacy,HP eradication rate were higher than the control group(all P<0.05),recurrence rate was lower than the control group(P<0.05),the differences were statistically significant.Conclusion:Qingwei decoction combined with quadruple therapy can effectively improve traditional Chinese medicine syndrome,promote ulcer healing,increase HP eradication rate and endoscopy efficacy,reduce ulcer recurrence rate,and significantly treat HP positive gastric ulcer.The mechanism may be related to the regulation of serum TGF-β1,ERK1/2 and EGFR in patients.

参考文献/References:

[1] 卜 爱,杜 姗.艾司奥美拉唑镁肠溶片治疗幽门螺杆菌相关性胃溃疡临床研究[J].陕西医学杂志,2019,48(10):1381-1383.
[2] Rahman Z,Dwivedi DK,Jena GB.Ethanol-induced gastric ulcer in rats and intervention of tertutylhydroquinone:Involvement of Nrf2/HO-1 signalling pathway[J].Hum Exp Toxicol,2020,39(4):547-562.
[3] 郭 静.三联疗法联合柴胡舒肝丸对幽门螺杆菌阳性胃溃疡患者幽门螺杆菌根除率及疗效的影响[J].中成药,2019,41(4):957-959.
[4] 冯正平,梁杏花,刘佛球.2191例消化性溃疡的胃镜和流行病学分析[J].重庆医学,2020,49(7):1114-1117.
[5] 闫文慧.除幽汤联合四联疗法对老年幽门螺杆菌相关性胃溃疡患者胃黏膜愈合及炎症反应的影响[J].中国老年学杂志,2020,40(5):978-981.
[6] 颉志英,张卫强,张志明,等.张志明主任医师治疗脾胃湿热型胃溃疡临床验案举隅[J].中医研究,2019,32(2):46-49.
[7] 张振山,姚天宇,许 迪.自拟清胃汤联合四联疗法治疗HP感染(脾胃湿热证)疗效观察[J].四川中医,2020,38(3):119-122.
[8] 张声生,黄恒青,方文怡,等.脾胃湿热证中医诊疗专家共识意见(2017)[J].中医杂志,2017,58(11):987-990.
[9] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:151-155.
[10] Takemoto T,Sasaki N,Tada M,et al.Evaluation of peptic ulcer healing with a highly magnifying endoscope[J].J Clin Gastroenterol,1991,13(11):125-128.
[11] 马 艳,毛志田.香砂六君子汤联合西药治疗HP阳性脾胃虚弱型消化性溃疡临床研究[J].陕西中医,2020,41(3):357-359.
[12] 张艳丽,王 聪,朱雷蕾,等.黄芩苷药理作用研究进展[J].河南中医,2019,39(9):1450-1454.
[13] 尤思路,李 娟,晏 陶,等.黄连-白术复方对小鼠胃溃疡模型的预防作用[J].中南大学学报:医学版,2020,45(1):8-16.
[14] 朱朝军,张朝晖,周 冰,等.偎脓长肉法对大鼠慢性溃疡组织病理学及肉芽组织VEGF、Notch1、TGF-β1表达的影响[J].中国中西医结合外科杂志,2020,26(1):8-14.
[15] 田 华,闫平慧,张锋利.黄连素对Hp相关性大鼠胃黏膜炎症及ERK1/2表达的影响[J].西部中医药,2019,32(8):1-4.
[16] 赵 威,鲁英杰,黄爱洁,等.埃索美拉唑对糜烂性胃溃疡患者血清ERK1/2及EGFR水平的影响[J].现代生物医学进展,2015,15(33):6501-6504.
[17] Chin C,Li J,Lee K,et al.Selective β2-AR blockage suppresses colorectal cancer growth through regulation of EGFR-Akt/ERK1/2 signaling,G1-phase arrest,and apoptosis[J].J Cell Physiol,2015,231(2):459-472.

相似文献/References:

[1]马 艳,毛志田.香砂六君子汤联合西药治疗HP阳性脾胃虚弱型消化性溃疡临床研究*[J].陕西中医,2020,(3):357.
　MA Yan,MAO Zhitian..Clinical study of Xiangsha Liujunzi decoction combined with western medicine in the treatment of HP positive peptic ulcer[J].,2020,(2):357.
[2]刘 睿,张 薇,杨 杰,等.降逆胃舒汤治疗萎缩性胃炎疗效及对患者病理评分的影响*[J].陕西中医,2020,(11):1539.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.006]
　LIU Rui,ZHANG Wei,YANG Jie,et al.Effect of Jiangni Weishu decoction on the pathological score of atrophic gastritis caused by helicobacter pylori infection[J].,2020,(2):1539.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.006]
[3]杨 荔,戴 蒙,唐亚萍,等.归脾汤合失笑散加味联合西药治疗消化性溃疡疗效研究[J].陕西中医,2021,(3):319.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.012]
[4]邹国辉,戴 祺,郑冰冰,等.调中化湿汤联合益生菌治疗HP相关性慢性胃炎合并缺铁性贫血临床研究[J].陕西中医,2021,(7):914.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.027]
[5]王 静,薛 蓓,尤强娜,等.延续性干预在加味黄芪建中汤治疗幽门螺杆菌阳性消化性溃疡中的作用[J].陕西中医,2022,(9):1226.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.017]
[6]陈思清,周赛男,韩运宗,等.黄芪建中汤对胃溃疡大鼠血清炎症因子、胃黏膜表皮生长因子受体表达的影响[J].陕西中医,2023,(8):1032.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.008]
　CHEN Siqing,ZHOU Sainan,HAN Yunzong,et al.Effect of Huangqi Jianzhong decoction on serum inflammatory factors and expression of gastric mucosal EGFR in rats with gastric ulcer[J].,2023,(2):1032.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.008]
[7]殷华芳,奚 蕾,沈卫东,等.名中医沈伟生基于“治未病”理念防治恶性肿瘤经验[J].陕西中医,2024,(10):1411.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.026]
　YIN Huafang,XI Lei,SHEN Weidong,et al.Shen Weisheng's experience in preventing and treating malignant tumors based on concept of “Preventive treatment of disease” theory[J].,2024,(2):1411.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.026]

备注/Memo

备注/Memo:
基金项目:河北省沧州市科学技术研究与发展指导计划项目(162302180)
更新日期/Last Update: 2021-01-28